Member Info for Porter_

Yes glaucoma is an industry worth $8bn a year with no proven preventative natural therapies. Great to see the intellectual portfolio growing. What is it 5 or 6 programmes now, so much going on I’m losing track!

Jeff Bezos would be nice 😆

Waiting for the 50:1 share consolidation next, so GR can convince all the loyal followers they’ve not had their investments wiped out

Strong feelings of turn around of delusion?

Prob needs the £600k as an advance to the administrators.

With £17m of creditors just on salaries as of June 24, it wouldn’t surprise me if the share suspends as soon as the funds are received.

Not sure why the FCA and OFSI haven’t stepped in, considering so many people in this group have complained daily for the past 5 years over George’s conduct???

Over 50% discount on the placing, that won’t even cover George’s food bill ☠️

Disposing of assets they’ve so far failed to get mining licenses for is not progress.

I read that RNS as a warning for investors to say your capital is at risk of being liquidated, as part of pre-insolvency protocol.

With those level of debts, I wouldn’t be surprised if the administrators are already on site.

Agree Northeast, decent cash reserves, having received €12m of funding on a €7m mcap.

- 22nd October 2024 - 4m Euro's non dilutive grant / loan (Wallonia Region)

- 30th May 2024 - 800,000 Euro's non dilutive grant (Government of Wallonia in Belgium's Advanced Therapy Medicinal Products)

- 4th April 2024 - £715,000 Capital Plus Partners placing, new TR1 private investor and new institutional investors

- 18th January 2024 - 1.34m Euro's non dilutive grant

- 18th January 2024 - 1.55m Euro's non dilutive grant

- 11th October 2022 - 250,000 Euro's non dilutive grant (Applied Research Programme of Enterprise Estonia)

- 16th March 2022 - 3.375m Euro's non dilutive grant (Regional Government of Wallonia)

Genflow has the exclusive license for this patent, 2 of its own patents pending and further expected to be lodged.

Good to have you onboard Hamodeh!

The work being completed by Genflow isn’t understood by the general public, but now that longevity and proactive healthcare are gaining priority over post decay reactive management, people are beginning to notice that Genflow could be a unicorn.

You won’t often find such an early stage Pharma share in receipt of EU backed grants, but Genflow did it!

The update on the patent application couldn’t have more perfect timing, what with all the buzz in the US and big pharma scurrying to align to the soon to be released longevity policies, as part of the new Pharma Bill.

I can see now why many of Genflow’s new institutional and fund investors are entering from the US and Canada, as they can see where this is going!

Would be lucky if there’s currently 100,000 shares in the freefloat based on tight hands. Would need to negotiate a deal with Eric and Tamara, or make a premium offer to current holders to prise their shares 😄

“The new fund supports of NaturalX, which has its first closing at €100m, supports proactive healthcare, filling a market gap as consumers take control of their own health journey... The venture capitalists’ €100m fund is dedicated to support European consumer health-focussed start-up companies that are active in sleep, mental health, probiotics and gut health, prevention, and longevity such as UK-based clock.bio, Storm Therapeutics, and GENFLOW BIOSCIENCES.”

https://european-biotechnology.com/latest-news/naturalx-secures-e100m-to-fuel-the-future-of-consumer-health-in-europe/

In the bin 🚮

I just can’t believe this Money. I have visions of Eric Leire spending the last few days fighting takeover offers and the offer price going up 100% every day 😂

Great news for Genflow and the longevity movement:

“RFK Jr sworn in as US Health and Human Services chief”

“The former presidential candidate will now oversee key health agencies with about 80,000 employees and a trillion-dollar budget.”

“He will now oversee agencies such as the Centers for Disease Control and Prevention (CDC), the Food and Drug Administration (FDA), the National Institutes of Health (NIH) and the Centers for Medicare and Medicaid Services.”

https://www.bbc.co.uk/news/articles/c626eezr76wo.amp

Agree, pretty amazing that the US Senate would call upon Eric Verdin to deliver a witness testimony on the Longevity industry.

Shows what a high calibre of specialists Genflow have, supporting them on their pathway to success!

Great speech from Eric Verdin, discussing why the US is a leader in longevity, that the industry has created many jobs, lives have been improved as a result of such research, and the financial benefits longevity science offers to the American economy, so funding is crucial for further growth!

https://www.linkedin.com/posts/buck-institute-for-research-on-aging_our-ceo-eric-verdin-answered-questions-about-activity-7295595546050707457--3wr?utm_medium=ios_app&rcm=ACoAACbKfB8B3qqXpdAJGmNM_uq35QOgdAWqzmE&utm_source=social_share_send&utm_campaign=copy_link

A few major US / Canadian financial institutions have also started to build a position in GENF, so the future is certainly looking bright at Genflow Biosciences.

Gives a nod to Genflow:

https://www.mewburn.com/news-insights/unlocking-immortality-the-innovations-driving-human-longevity